Characterization of the binding of /sup 3/H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum
A novel benzazepine, SCH 23390, has recently been described as a very potent and selective dopamine D-1 receptor antagonist based on its potent inhibition of dopamine sensitive adenylate cyclase and its selective displacement of /sup 3/H-piflutixol from rat striatal receptor sites. In the present study, the in vitro binding of /sup 3/H-SCH 23390 to specific striatal receptor sites has been characterized. Binding was saturable and stereospecific, and the results of both saturation and competition studies are consistent with the binding of /sup 3/H-SCH 23390 to a single striatal site. A K/sub D/ of 0.53 nM was obtained through Scatchard analysis. Relative potencies of a variety of neuroleptics in competing with /sup 3/H-SCH 23390 and also /sup 3/H-spiperone support an interpretation that the single site to which /sup 3/H-SCH 23390 binds is the D-1 dopamine receptor. Also, the binding capacity of /sup 3/H-SCH 23390 (69 pmoles/gm wet weight) is in agreement with published values for the binding capacities of /sup 3/H-piflutixol and /sup 3/H-flupentixol. These data, coupled with the low level of non-specific binding encountered with this radioligand (4-8% ot total binding at normally employed ligand concentration of 0.3 nM), its high specific activity and its negligible binding to plastic and glass surface make it ideally suited for studying interactions with this receptor.
- Research Organization:
- Schering-Plough Corp., Bloomfield, NJ
- OSTI ID:
- 6241826
- Journal Information:
- Life Sci.; (United States), Journal Name: Life Sci.; (United States) Vol. 35:18; ISSN LIFSA
- Country of Publication:
- United States
- Language:
- English
Similar Records
Comparison between dopamine-stimulated adenylate cyclase and /sup 3/H-SCH 23390 binding in rat striatum
( sup 125 I)(+)FISCH: A new CNS D-1 dopamine receptor imaging ligand
Related Subjects
59 BASIC BIOLOGICAL SCIENCES
AFFINITY
AMINES
ANIMALS
ANTIDEPRESSANTS
AROMATICS
AUTONOMIC NERVOUS SYSTEM AGENTS
CARDIOTONICS
CARDIOVASCULAR AGENTS
CENTRAL NERVOUS SYSTEM AGENTS
CHEMICAL BONDS
DOPAMINE
DRUGS
HYDROXY COMPOUNDS
IN VITRO
ISOTOPE APPLICATIONS
LABELLED COMPOUNDS
LIGANDS
MAMMALS
MUSCLES
NEUROREGULATORS
ORGANIC COMPOUNDS
PHENOLS
POLYPHENOLS
PSYCHOTROPIC DRUGS
RADIOASSAY
RATS
RECEPTORS
RODENTS
SYMPATHOMIMETICS
TRACER TECHNIQUES
TRITIUM COMPOUNDS
VERTEBRATES